# Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity

> **NCT02319668** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 38 (actual)

## Conditions studied

- Dental Prophylaxis and Implant Surgery

## Interventions

- **DRUG:** 0.2% w/v Chlorhexidine digluconate
- **DRUG:** Sodium fluoride toothpaste (Aquafresh Mild & Minty)

## Key facts

- **NCT ID:** NCT02319668
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-01
- **Primary completion:** 2015-06-01
- **Final completion:** 2016-02-29
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319668, "Antimicrobial Agent for Reducing Bacteria in Aerosols and Oral Cavity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02319668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*